A multicentre randomized phase III trial comparing pembrolizumab (P) vs single agent chemotherapy (CT) for advanced pre-treated malignant pleural mesothelioma (MPM): Results from the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni Fontecedro, Varvara Polydoropoulou et al. · Annals of Oncology · 2019

Cited by 55 works. doi:10.1093/annonc/mdz394.091

Authors